6393 results
BJPsych open,
Volume 11, Issue 6, 10 2 2025, Pages e271
Reducing functional dysconnectivity in people with schizophrenia spectrum disorders.
Wunderlich S, Keeser D, Spaeth J, Yilmaz D, Maurus I, Alici C, Schmitt A, Falkai P, Stoecklein S, Roell L
Background: The dysconnection hypothesis of schizophrenia posits that widespread synaptic inefficiencies lead to altered macroscale brain connectivity, contributing to symptom severity and cognitive deficits in individuals with schizophrenia spectrum disorders (SSD). Emerging evidence suggests that physical exercise may help to ameliorate these connectivity abnormalities and associated clinical impairments. Aims: This study investigated whether reductions in functional dysconnectivity following...
Abstract
Cited 1 times since 2025 (14.8 per year)
source: EuropePMC
NEJM evidence,
10 2 2025, Pages EVIDoa2500268
Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.
Van't Hof AWJ, Gibson CM, Rikken SAOF, Januzzi JL, Granger CB, van Beurden A, Rasoul S, Ruiters L, Vainer J, Verburg A, Arslan F, Jukema JW, Durieux M, Polad J, van Vliet R, van den Branden BJL, Magro M, Remkes W, Beelen J, Hermanides R, Tolsma R, Gosselink M, Vinereanu D, Chioncel V, van de Hoef TP, Boomars R, Arkenbout KE, van Houwelingen GK, Hengstman G, van de Wetering H, Pisters R, Kala P, Merkely B, Ecollan P, Lapostolle F, Giugliano RP, Welsh RC, Levy M, Arias-Mendoza A, Baron N, Cociorva D, Wittes J, Unger EF, Coller BS, Ten Berg JM, Montalescot G
Background: Zalunfiban is a glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor designed for subcutaneous administration on first medical contact with patients with suspected ST-segment elevation myocardial infarction (STEMI). Methods: An international, double-blind, placebo-controlled trial randomly assigned patients with STEMI in a 1:1:1 ratio to receive a single subcutaneous injection of zalunfiban (0.11 mg/kg or 0.13 mg/kg) or placebo. The primary efficacy end point was a hierarchical proporti...
Abstract
Thrombosis research,
Volume 256, 9 2 2025, Pages 109533
Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED score.
van der Horst SFB, Chu G, Seelig J, Trinks-Roerdink EM, Voorhout L, de Vries TAC, van Alem AP, Beukema RJ, Boersma LVA, Brouwer MA, Ten Cate H, Faber LM, de Groot JR, Gu YL, den Hartog FR, de Jong JSSG, de Jong Y, Kirchhof CJHJ, Kleijwegt FS, Klok FA, Kruip MJHA, Lenderink T, Luermans JG, Meeder JG, Otten AM, Pisters R, Pos L, Prins FJ, Römer TJ, Smeets F, Tahapary GJM, Theunissen LJHJ, Tieleman RG, Timmer SAJ, Tichelaar V, Trines SA, van der Voort P, Velthuis S, de Vrey EA, Walhout RJ, Hemels MEW, Rutten FH, Geersing GJ, Huisman MV
Background: Atrial fibrillation/flutter (AF/AFL) is associated with an increased stroke risk, for which oral anticoagulation (OAC) is often indicated. Bleeding risk assessment is crucial in these patients to mitigate bleeding complications, yet AF guidelines do not recommend the use of any bleeding risk score (e.g., HAS-BLED) due to concerns about predictive accuracy. The AF-adapted VTE-BLEED (AF-BLEED) score was developed to predict major bleeding (MB) post-OAC initiation. Aims: Evaluate the in...
Abstract
The Journal of invasive cardiology,
7 1 2025
Vascular access and mortality outcomes: insights from the Percutaneous Coronary Interventions registry from the Netherlands Heart Registration.
Karalis I, Timmermans MJ, Tuccillo A, Jukema JW, Derks L, Verbeek EC, Amoroso G, PCI Registration Committee of the Netherlands Heart Registration (NHR)
Objectives: While the transradial approach (TRA) is associated with fewer bleeding complications than the transfemoral approach (TFA), its effect on mortality outcomes in real-world clinical practice remains unclear. This study examines the relationship between vascular access site and mortality in patients undergoing percutaneous coronary intervention (PCI). Methods: This retrospective cohort study used prospectively collected data from the Netherlands Heart Registration, including 130,813 PCI...
Abstract
Multiple sclerosis (Houndmills, Basingstoke, England),
Volume 31, Issue 14, 6 1 2025, Pages 1641-1650
Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis.
Yang JH, Race J, Sumowski P, Jacques K, Fardad S, Fair A, Hazlett A, Lin J, Yilmaz D, Aaen G, Abrams A, Benson L, Casper TC, Chitnis T, Gorman M, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Barcellos LF, Waubant E, Graves JS
Background: Age is the strongest factor determining disease expression in multiple sclerosis (MS). We previously demonstrated biological age acceleration in pediatric-onset MS (POMS) compared to controls with both epigenetic clocks (DNAm) and telomere length (TL). It is unknown whether these markers report overlapping or distinct aging-related processes. Objectives: To determine the correlation between DNAm and TL aging markers. Methods: We conducted a cross-sectional case-control study within t...
Abstract
Journal of the American Heart Association,
Volume 14, Issue 22, 6 1 2025, Pages e040726
Prognostic Value of a Coronary Computed Tomography Angiography-Derived Ischemia Algorithm: Comparison Against Hybrid Coronary Computed Tomography Angiography/Positron Emission Tomography Imaging.
Maaniitty T, Bär S, Nabeta T, Bax JJ, Saraste A, Knuuti J
Background: Artificial intelligence-guided quantitative computed tomography ischemia (AI-QCTischemia) is a novel machine-learning method for predicting myocardial ischemia from coronary computed tomography angiography (CCTA). This observational cohort study aimed to compare the long-term prognostic value of AI-QCTischemia with hybrid CCTA/positron emission tomography (PET) myocardial perfusion imaging in suspected coronary artery disease (CAD). Methods: Symptomatic patients with suspected CAD un...
Abstract
Journal of manipulative and physiological therapeutics,
5 1 2025, Pages S0161-4754(25)00063-6
Effectiveness of Thoracic Spine Manipulation for Upper Quadrant Musculoskeletal Disorders: A Systematic Review.
Thoomes EJ, Tilborghs G, Heneghan NR, Falla D, De Graaf M
Objective: Thoracic high-velocity low-amplitude thrust (Tx-HVLAT) manipulation is a form of conservative management recommended as an effective treatment option for patients with upper quadrant musculoskeletal disorders (UQMD). This systematic review aimed to update the current evidence on the effectiveness of Tx-HVLAT for patients with UQMD on pain, disability, and performance outcome measures. Methods: Electronic libraries of the Cochrane Controlled Trials Register, MEDLINE, EMBASE, CINAHL, PE...
Abstract
American heart journal,
Volume 292, 3 1 2025, Pages 107295
Evolocumab before percutaneous coronary intervention for acute myocardial infarction: Design of the AMUNDSEN trial.
Montalescot G, Bolognese L, Bartus S, Cequier-Fillat A, Thiele H, Mach F, Jukema JW, Ferrari E, Souteyrand G, Bouleti C, Range G, Chioccioli M, Picchi A, Batias-Moreau L, Esposito G, Braik N, Redjimi N, Duband B, Guedeney P, Zeitouni M, Brochard K, Silvain J, Vicaut E, AMUNDSEN investigators of the ACTION Study Group
Rationale: PCSK9 inhibitors are currently recommended as third-line therapy for post-myocardial infarction (MI) patients, added to high-dose statin, ezetimibe, and potentially bempedoic acid when the LDL-C target of
Abstract
Cited 30 times since 2025 (324.9 per year)
source: EuropePMC
European heart journal,
Volume 46, Issue 44, 1 1 2025, Pages 4635-4736
2025 ESC/EACTS Guidelines for the management of valvular heart disease.
Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, Ajmone Marsan N, Barili F, Bonaros N, Cosyns B, De Paulis R, Gamra H, Jahangiri M, Jeppsson A, Klautz RJM, Mores B, Pérez-David E, Pöss J, Prendergast BD, Rocca B, Rossello X, Suzuki M, Thiele H, Tribouilloy CM, Wojakowski W, ESC/EACTS Scientific Document Group
Abstract
Lancet (London, England),
Volume 406, Issue 10519, 1 1 2025, Pages 2577-2587
Contemporary, non-invasive imaging diagnosis of chronic coronary artery disease.
van der Bijl P, Gulati M, Saraste A, Marwick T, Kwong R, Blankstein R, Nieman K, Sengupta PP, van Rosendael A, Knuuti J, Bangalore S, Bax JJ
Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an acute coronary syndrome, it is often characterised by long periods of stability, known as chronic coronary artery disease. This Review presents a comprehensive overview of the diagnosis of the disease, with a focus on cardiac imaging. We discuss various cardiac imaging modalities, including CT coronary angiography, stress echocardiogram, stress single-photon emission CT, PET...
Abstract
Annals of vascular surgery,
Volume 123, 1 1 2025, Pages 502-513
Rupture Risk of Large Abdominal Aortic Aneurysms: A Scoping Review.
Paping JHM, Bulder RMA, Lancaster E, Chang RW, Putter H, Hamming JF, Lindeman JH
Background: Abdominal aortic aneurysm (AAA) management is currently dictated by the 55 mm intervention threshold. While it has been suggested that this intervention threshold is too conservative, the rupture risk of AAAs larger than 55 mm is discussed differently. This scoping review aims to critically summarize and review the available evidence with respect to the rupture risk of larger AAA. Methods: A quantitative and qualitative evaluation of the available literature on the rupture risk of la...
Abstract
Journal of cellular and molecular medicine,
Volume 29, Issue 21, 1 1 2025, Pages e70933
Breaking (Light) Barriers: Photoacoustics in Atherosclerotic Diseases.
van Dijk K, de Vries MR
Photoacoustic imaging (PAI) is an emerging imaging modality that provides high-resolution, spatiotemporal insights into anatomical structures, functional parameters and molecular characteristics of tissues. By leveraging both endogenous absorbers, such as lipids and collagen, and exogenous contrast agents like nanoparticles and molecular dyes, PAI offers a comprehensive approach to characterising atherosclerosis. This review describes the technical principles underlying various PAI modalities an...
Abstract
Journal of cardiac failure,
Volume 31, Issue 11, 1 1 2025, Pages 1661-1671
Diagnosing HFpEF in Patients With Unexplained Dyspnea by Using Invasive Left Ventricular Pressure-Volume Loops.
Gessner R, Hübner AC, Stöbe S, Rudolph UM, Unger L, Schmeisser A, Steendijk P, Uhe T, Stegmann T, Lavall D, Hagendorff A, Laufs U, Wachter R
Background: Diagnosing heart failure with preserved ejection fraction (HFpEF) remains challenging. Noninvasive diagnostic algorithms have been proposed but not tested against the gold standard, ie, invasive measurement of left ventricular (LV) pressure-volume loops (PVL). This study's aim was to estimate the prevalence of HFpEF in euvolemic patients with unexplained exertional dyspnea by using LV PVL and to validate noninvasive diagnostic algorithms. Methods and results: We included patient...
Abstract
The British journal of surgery,
Volume 112, Issue 11, 1 1 2025, Pages znaf177
The science and art of decision-making in surgery.
Bisset CN, Baigrie R, Dames N, Corbett S, Hill S, Macdermid E, Sier VQ, van der Vorst JR, Rehman U, Sarwar MS, Brennan PA, Cleland J, Ellis R, Bryan JE, Ketley A, Morgan JL, Gogalniceanu P, Kaafarani HMA, Liang R, Moug SJ
Abstract
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology,
Volume 80, 31 5 2025, Pages 107789
Aortic wall lamellar structure in phylogeny and in humans: insights from bicuspid and tricuspid aortic valve morphology.
Bacour N, Zafar M, Kargin N, Zinganshin B, Poelmann R, Klautz RJM, Elefteriades J, Grewal N
Objective: Despite a voluminous literature on aortopathy, comparatively little attention has been paid to the lamellar architecture of the aortic wall, including the number and distribution of these layers. This study compares the lamellar organization of the developing aorta in individuals with a bicuspid (BAV) versus tricuspid aortic valve (TAV) and includes a literature review on aortic lamellae in mammals and adult humans. Methods: Non-dilated ascending aortic wall samples (n = 83) were anal...
Abstract
American heart journal,
31 5 2025, Pages 107296
Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and Design of the POPular ACE TAVI trial.
Overduin DC, van Ginkel DJ, Dubois C, Lesizza P, Broeze GM, Montero-Cabezas JM, Rosseel L, van der Kley F, van Nuland PJ, Smits TP, Hemelrijk KI, Aarts HM, Rensing BJWM, Timmers L, Swaans MJ, Sonker U, Veenstra L, van 't Hof AWJ, Peper J, Tijssen JGP, Delewi R, Vriesendorp PA, Ten Berg JM
Background: Unfractionated heparin is routinely used during transcatheter aortic valve implantation (TAVI) to reduce catheter thrombosis and thromboembolism. Protamine reverses the effect of heparin and may lower bleeding risk, but it can also trigger severe allergic reactions. Robust data on the safety and efficacy of routine protamine administration after TAVI is lacking. Methods: The 'Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter A...
Abstract
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
31 5 2025, Pages S0894-7317(25)00608-X
Reply to "Optimizing clinical applicability of left atrial strain index in patients with heart failure with preserved ejection fraction".
Chua AP, Marsan NA
Abstract
JACC. Cardiovascular imaging,
30 5 2025, Pages S1936-878X(25)00549-2
Can Cardiac Computed Tomography Refine Prognosis in Tricuspid Regurgitation?
Ajmone Marsan N
Abstract
International journal of cardiology. Congenital heart disease,
Volume 22, 30 5 2025, Pages 100636
Cardiac autonomic function in patients with single ventricle physiology after Fontan palliation: A literature review.
Polyakova E, Nederend M, Kies P, Egorova AD, Jongbloed MRM
Background: The Fontan operation has significantly improved survival in patients with single ventricle physiology. This comes at a price of highly prevalent long-term complications. Autonomic dysfunction has been documented in patients after Fontan palliation. Although autonomic dysfunction is associated with a range of adverse outcomes, the exact clinical implications in patients with a Fontan circulation remain unclear. Aims: The aims of this review are to address (1) the extent and characteri...
Abstract
JACC. Advances,
Volume 4, Issue 11 Pt 1, 24 4 2025, Pages 102250
Drug-Coated Balloon After Intravascular Lithotripsy: Procedural and Clinical Outcome of the "Crack and Drug" Strategy.
Oliveri F, van Oort MJH, Phagu AAS, Al Amri I, Bingen BO, Paradies V, Mincione G, Claessen BEPM, Dimitriu-Leen AC, Kefer J, Girgis H, Vossenberg T, Mandurino-Mirizzi A, Van der Kley F, Jukema JW, Montero-Cabezas J
Background: Drug-eluting stents (DESs) after intravascular lithotripsy (IVL) have proven effective in calcified coronary lesions. However, evidence supporting drug-coated balloons (DCBs) after IVL remains limited. Objectives: We aimed to compare the technical success and 1-year clinical outcomes of IVL + DES vs IVL + DCB strategies for the treatment of balloon-crossable calcified coronary lesions. Methods: Patients undergoing percutaneous coronary intervention with IVL from the prospective BENEL...
Abstract
